35 programming-"the"-"DAAD"-"IMPRS-ML"-"U.S"-"FEMTO-ST"-"Prof" "UCL" Fellowship positions
Sort by
Refine Your Search
-
– fitness made convenient Employee Assistance Programme – for confidential wellbeing support when you need it Whether you're looking to grow your career or simply find a better balance, UCL could be the right
-
About us The UCL Institute for Global Health (IGH) is at the heart of UCL’s Grand Challenge of Global Health. The Institute’s vision is for a world where international policy on global health is
-
About us The UCL Institute for Global Health (IGH) is at the heart of UCL’s Grand Challenge of Global Health. The Institute’s vision is for a world where international policy on global health is
-
organoid models of neurodevelopmental diseases to test advanced genetic therapies. It will be supervised by Professor Gabriele Lignani and is in collaboration with Dr Amy McTague at UCL Institute of Child
-
About us The “Next-Gen Biopharma Manufacturing 5.0” Prosperity Partnership is a 5-year collaborative programme between UCL Biochemical Engineering and AstraZeneca, jointly funded by EPSRC and
-
About us The “Next-Gen Biopharma Manufacturing 5.0” Prosperity Partnership is a 5-year collaborative programme between UCL Biochemical Engineering and AstraZeneca, jointly funded by EPSRC and
-
About us The UCL Institute for Global Health (IGH) is at the heart of UCL’s Grand Challenge of Global Health. The Institute’s vision is for a world where international policy on global health is
-
About us The “Next-Gen Biopharma Manufacturing 5.0” Prosperity Partnership is a 5-year collaborative programme between UCL Biochemical Engineering and AstraZeneca, jointly funded by EPSRC and
-
About us The “Next-Gen Biopharma Manufacturing 5.0” Prosperity Partnership is a 5-year collaborative programme between UCL Biochemical Engineering and AstraZeneca, jointly funded by EPSRC and
-
About us The “Next-Gen Biopharma Manufacturing 5.0” Prosperity Partnership is a 5-year collaborative programme between UCL Biochemical Engineering and AstraZeneca, jointly funded by EPSRC and